The size of the global thrombectomy devices market is forecasted to value USD 1.84 billion by 2028 from USD 1.28 billion in 2023, growing at a CAGR of 7.4% during the forecast period.
Thrombectomy devices are used to remove clots from a blood vessel performed in an interventional procedure. It is generally used as a last resort as continuous blockage of blood flow to organs can lead to a situation known as necrosis. During a procedure, these devices will minimize the damage to the vessel wall. Thrombectomy devices can even be used to treat deep vein thrombosis, pulmonary embolism, neurovascular thrombosis conditions, and peripheral arterial, according to the size and diameter and depending on the affected area. Balloon embolectomy, aspiration embolectomy, and surgical embolectomy are the most used thrombectomy device procedures.
The growing patient count suffering from CVDs is one of the major factors propelling the global thrombectomy devices market growth.
The usage of thrombectomy devices has increased with the growing population suffering from cardiovascular diseases. According to the data published by the Centers for Disease Prevention and Control (CDC), for every second, one person in the United States is getting a heart attack, and an estimated 805,000 heart attacks are being recorded in the United States every year. These devices help eliminate the blood clots from the blood vessels and can help restore the blood flow and prevent the complications of CVDs such as stroke and heart attack. Therefore, the increasing incidence of cardiovascular diseases worldwide is estimated to promote the demand for thrombectomy devices, as these conditions need immediate medical assistance to avoid serious health situations. In addition, rising awareness levels regarding the benefits associated with thrombectomy procedures and the growing adoption of minimally invasive surgeries are anticipated to result in the growth of the thrombectomy devices market.
In addition, the growing adoption of sedentary lifestyles and increasing demand for minimally invasive surgeries are accelerating the growth rate of the thrombectomy devices market. Furthermore, the growing aging population is expected to contribute to the growing demand for thrombectomy devices in the coming years. The increase in the geriatric population leads to evolving various disease conditions, which must have surgical interventions for treatment. This promotes the demand levels for these devices and boosts the market’s growth rate. Moreover, increasing the target patient population is boosting the thrombectomy devices market. In addition, the rise in technological innovations in the medical field and the increasing prevalence of cardiovascular diseases are significant market growth opportunities. Moreover, the increase in research and development investments is boosting the thrombectomy devices market.
The lack of skilled professionals is the major restrain to the thrombectomy devices market. In addition, the high cost associated with thrombectomy devices is hampering the global market. Moreover, the difficulty of using new equipment is constraining the thrombectomy devices market growth. In addition, the lack of awareness about peripheral vascular diseases in emerging countries is challenging market growth. Moreover, the side effects of using thrombectomy devices, such as bleeding from the catheter inserted and the presence of bruce in the area causing pain, are hindering the growth rate of the thrombectomy devices market.
Impact of COVID-19 on the global thrombectomy devices market:
COVID-19 is caused due to the SARS-CoV-2 virus at the end of 2020. Since the WHO declared the COVID-19 pandemic, their were lockdown restrictions around the globe. The implementation of the lockdown has caused an immense global economic crisis. Nearly all the industries in every sector were affected individually. The thrombectomy devices Market had a negative impact during the COVID. As there was a strict implementation of the lockdown, emergency surgeries such as endovascular thrombectomy (EVT) were delayed or rescheduled, which impacted the market's growth. Moreover, the supply chain system got disturbed, and the after-sales service was delayed due to pandemics, hampering market growth. The delay in investments and funds is pausing the production of thrombectomy devices, which thwarted the market. The key players in the market are trying their best to introduce new devices to survive in the competition after the pandemic.
Market Size Available
2022 to 2028
2023 to 2028
By Type, Application, End-User, Disease, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
This research report on the global thrombectomy devices market has been segmented and sub-segmented based on type, application, end-user, disease, and region.
Thrombectomy Devices Market - By Type:
Based on type, the mechanical thrombectomy devices segment is anticipated to account for the largest share of the global thrombectomy devices market in 2022. The dominance of the segment is expected to continue during the forecast period. The growing requirement for stent retrievers and supportive reimbursement policies are propelling the growth of the mechanical thrombectomy devices segment. Acandis and Sela Medical are some of the notable manufacturers of mechanical thrombectomy devices. Moreover, mechanical thrombectomy devices are more effective in reducing stroke-related disability and mortality. Therefore, the segment of stent retrievers is estimated to showcase promising growth during the forecast period.
Thrombectomy Devices Market - By Application:
Based on the application, the cardiovascular segment had the major share of the global market in 2022. The growing incidence of CVDs worldwide is one of the major factors driving segmental growth. In addition, the benefits of mechanical thrombectomy in heart surgeries and the rise in minimally invasive cardiac surgeries propel the cardiovascular disease segment.
On the other hand, the neurovascular application segment is gaining attention and is anticipated to grow at a prominent CAGR during the forecast period.
Thrombectomy Devices Market - By End User:
Based on the end-user, the hospital surgical centers dominated the market in 2022 and are estimated to hold a notable share of the global market during the forecast period owing to the growing number of people suffering from chronic vascular diseases and the rise in ultrasonic thrombectomy clinical applications.
Thrombectomy Devices Market - By Diseases:
The coronary diseases segment led the market in 2022. The segment’s dominance is anticipated to continue throughout the forecast period owing to rising awareness among people over the availability of quality treatment procedures in developed and developing countries.
Thrombectomy Devices Market - By Region:
Geographically, The thrombectomy devices market in North America held the largest share of the global market in 2022, and the region’s dominance is expected to continue in the coming years. The presence of key market participants and increased adoption of technological developments in manufacturing thrombectomy devices propel the market growth in North America. In addition, the rising aging population and incidence of cardiovascular diseases are further fuelling the growth rate of the North American region. The major contributors to the North American market are the US and Canada. For instance, according to the CDC, Stroke is the fifth major cause of death in the United States, with 130,000 deaths yearly.
Moreover, 800,000 people have a stroke every year. In addition, the increased incidence of cardiovascular diseases and technological advancements in the medical field propel the market. Furthermore, numerous vital players are boosting the thrombectomy devices market in North America.
The European thrombectomy devices market is expected to account for the second-largest market share in the world during the forecast period. During the forecast period, the European market is projected to grow at a healthy CAGR. The growing incidence of cardiovascular diseases and the increasing geriatric population contribute to the growth of the European thrombectomy devices market. Germany accounted for the largest share of the European region in 2021 and is estimated to continue dominating the European market in the coming years.
The thrombectomy devices market in the Asia Pacific is the fastest-growing market globally. The presence of local manufacturers and growing distribution networks are accelerating the market growth in this region. India is a major contributor to the Asia-Pacific market. The rising adoption of thrombectomy devices and the rising patient count suffering from cardiovascular diseases support the thrombectomy devices market in the Asia-Pacific region. In addition, factors such as the large patient population and growing awareness among healthcare professionals regarding the advantages associated with using thrombectomy devices are favoring the regional market growth.
The thrombectomy devices market in Latin America is expected to grow steadily during the forecast period owing to the growing geriatric population, rising prevalence of cardiovascular diseases, growing adoption of a sedentary lifestyle, increasing demand for minimally invasive procedures, and technological innovations in the medical field. However, some of the restraints in this market are difficulty using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases.
The thrombectomy Devices Market in the Middle East & Africa is forecasted to grow at a sluggish growth rate and hold a moderate share of the global market in the coming years.
KEY MARKET PARTICIPANTS:
Companies playing a noteworthy role in the global thrombectomy devices market and profiled in this report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).
The global thrombectomy devices market size was valued at 1.6 billion in 2021.
The Asia-Pacific region is anticipated to grow the fastest in the global thrombectomy devices market during the forecast period.
Yes, we have studied and included the COVID-19 impact on the global thrombectomy devices market in this report.
Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.) are some of the noteworthy companies in the thrombectomy devices market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]